For instance, both PDAC and TC shared activation of the TWEAK and SPP1 pathways on cancer cells despite their opposing malignancy, suggesting that cancer aggressiveness may depend more on the immune and stromal context—such as CXCR2 TAN enrichment or pericyte abundance—than on individual oncogenic signaling events. This evidence concerns the gene CXCR2 and cancer.